ERNA vs NVDA · P/E 0.0, rev $582.0K vs P/E 58, rev $96.22B
Eterna Therapeutics Inc (ERNA) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the ERNA and NVDA stock pages for the full models.
Not investment advice.